Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery
- PMID: 11755844
- DOI: 10.1016/s0002-9394(01)01295-8
Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery
Abstract
Purpose: To report the use of perfluorohexyloctane, a liquid semifluorinated alkane that is heavier than water, as an internal tamponade agent in surgery for complicated retinal detachments.
Design: A consecutive interventional case series from three study centers.
Methods: In 23 consecutive eyes (23 patients, 19 men and four women, mean +/- standard deviation (SD) age of 58.5 years +/- 16.1) perfluorohexyloctane was used for long-term internal tamponade. Included were eyes with complicated retinal detachment involving the lower two quadrants of the fundus. Excluded were patients with diseases in the fellow eye or severe systemic disease. A pars plana vitrectomy was performed, including membrane peeling and retinotomy where necessary.
Results: The mean duration for perfluorohexyloctane being left in situ was 76 days (SD 37.64) (range, 35-202 days). Four weeks following the removal of perfluorohexyloctane 19 of the 23 patients had total reattachment of the retina; three eyes had a recurrence of retinal detachment. One patient was lost to follow-up. The mean follow-up after perfluorohexyloctane removal was 97 days (range, 48 to 169 days). Cataract formation or progression was noted in nine of the 10 eyes. There were two cases with high intraocular pressures. Dispersion into small droplets was observed as early as 3 days postoperatively in three of the 23 patients. At least 12 of the 23 patients had an obvious dispersion by the time of perfluorohexyloctane removal. There was no sign of optic atrophy, retinal necrosis, or retinal vascular occlusion.
Conclusion: Perfluorohexyloctane was tolerated as a long-term internal tamponade agent without obvious signs of damage to the retina or optic disk. Of all the complications noted, the most common was that of dispersion of the perfluorohexyloctane bubble into droplets.
Similar articles
-
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.Am J Ophthalmol. 2003 Sep;136(3):454-63. doi: 10.1016/s0002-9394(03)00241-1. Am J Ophthalmol. 2003. PMID: 12967798 Clinical Trial.
-
The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment.Graefes Arch Clin Exp Ophthalmol. 2006 Jun;244(6):709-16. doi: 10.1007/s00417-006-0317-3. Epub 2006 Mar 21. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16550400
-
Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery.Retina. 2005 Jun;25(4):479-88. doi: 10.1097/00006982-200506000-00014. Retina. 2005. PMID: 15933596
-
Inflammation induced by perfluorocarbon liquid: intra- and postoperative use.Biomed Res Int. 2014;2014:907816. doi: 10.1155/2014/907816. Epub 2014 Mar 24. Biomed Res Int. 2014. PMID: 24783224 Free PMC article. Review.
-
Perfluorohexyloctane.2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2025 Jan 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 39836820 Free Books & Documents. Review.
Cited by
-
Vitreous Substitutes as Drug Release Systems.Transl Vis Sci Technol. 2022 Sep 1;11(9):14. doi: 10.1167/tvst.11.9.14. Transl Vis Sci Technol. 2022. PMID: 36125790 Free PMC article. Review.
-
Long-Term Safety and Efficacy of Siluron2000 with Pars Plana Vitrectomy in the Treatment of Patients with Severe Vitreoretinopathy and Chronic Macular Holes.Clin Ophthalmol. 2021 Nov 2;15:4373-4379. doi: 10.2147/OPTH.S338269. eCollection 2021. Clin Ophthalmol. 2021. PMID: 34754177 Free PMC article.
-
Heavy silicone oil (Densiron-68) for the treatment of persistent macular holes: Densiron-68 endotamponade for persistent macular holes.Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1471-6. doi: 10.1007/s00417-009-1131-5. Epub 2009 Aug 1. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19649646
-
F4H5 Alleviates Increased Outflow Resistance Induced by Emulsified Silicone Oil In Vitro.Invest Ophthalmol Vis Sci. 2025 Aug 1;66(11):21. doi: 10.1167/iovs.66.11.21. Invest Ophthalmol Vis Sci. 2025. PMID: 40778700 Free PMC article.
-
[Advantages and disadvantages of heavy silicone oil].Ophthalmologe. 2010 Jun;107(6):566, 568-70. doi: 10.1007/s00347-010-2215-7. Ophthalmologe. 2010. PMID: 20532517 German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
